A B S T R A C T slc7a5 (also known as LAT1), largely accepted as an amino acid transporter, has been shown to play important roles in cancer and developmental processes. Because knockout mice of Slc7a5 are embryonically lethal due to placental defects, it is difficult to evaluate its role in early development. In this study, expression and function of slc7a5 were evaluated in Xenopus laevis embryos that develop without a placenta. Expression of slc7a5 was detected in the notochord and in the eye and it was not co-localized with slc3a2, which helps slc7a5 to localize at the plasma membrane, before the late neurula stage. Loss-of-function experiment with a morpholino antisense oligonucleotide led to defect of neural and non-neural patterning, inhibition of primary neurogenesis, and disruption of eye development. Disruption of neural development and primary neurogenesis was likely due to impaired notochord development as sonic hedgehog (shh) signaling pathway was compromised in slc7a5-inhibited embryos. These results suggest that slc7a5 is required for notochord development and subsequent primary neurogenesis via shh/gli signaling and for eye development. These novel developmental roles of slc7a5 appeared to be independent of transport function at least before the late neurula stage.
Introduction
SLC7A5 (solute carrier family 7 member 5, widely accepted as LAT1) is an amino acid transporter initially identified by two groups, Kanai et al. ( in rat C6 glioma cells) and Mastroberardino et al. (in human) in 1998 (Kanai et al., 1998; Mastroberardino et al., 1998) . It localizes to the plasma membrane accompanied by a type II membrane protein, SLC3A2 (also called 4F2hc or CD98) (Mastroberardino et al., 1998; Nakamura et al., 1999) and contributes to uptake of large neutral amino acids (e.g. leucine or phenylalanine) into cells in a sodium ionindependent manner (Kanai et al., 1998; Mastroberardino et al., 1998; Prasad et al., 1999) .
Although SLC7A5 is expressed in various normal tissues, such as the brain and placenta in humans and rodents (Chrostowski et al., 2009; Kanai et al., 1998; Prasad et al., 1999) , it has been shown to be expressed in tumor cells and its degree of expression is more prominent as the tumor evolves to a more malignant phenotype (Sakata et al., 2009; Yanagisawa et al., 2012) . As its substrates, especially leucine, are shown to stimulate mTOR (mammalian target of rapamycin) pathway and lead to tumor cell proliferation (Kimball and Jefferson, 2004) , SLC7A5 can be a novel target for cancer therapy. In fact, several reports including ours have been published showing that inhibition of this transporter by BCH (2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid) or JPH203 ((S)-2-amino-3-(4-((5-amino-2-phenylbenzo[d]oxazol-7-yl) methoxy)-3,5-dichlorophenyl)-propanoic acid) represses the proliferation of tumor cells in vitro or in vivo (Cormerais et al., 2016; Kim et al., 2008; Oda et al., 2010; Rosilio et al., 2015; Ueno et al., 2016; Yun et al., 2014) . In addition to tumor cells, it has been shown that SLC7A5 is highly expressed in fetal tissues. For example, Nakada et al. have shown that SLC7A5 is detected in the cardiac muscle, hepatocyte and thymic epithelial cells in human fetuses but not in the respective adult tissues (Nakada et al., 2014) . Taken together, it seems that amino acid uptake by SLC7A5 is important for cell proliferation both in malignant tumors and normal development.
We were interested in elucidating a role for SLC7A5 in normal developmental processes. Specifically, we would like to know whether perturbation of SLC7A5 only leads to slower growth or more profound effects during organogenesis. Recently, 3 groups have reported that complete loss of Slc7a5 function leads to embryonic lethality in mice (Ohgaki et al., 2017; Poncet et al., 2014; Sinclair et al., 2013) , suggesting that Slc7a5 is essential for early developmental processes. Ohgaki et al. have shown that labyrinth development is disrupted in the Slc7a5 −/− placenta and that the Slc7a5 −/− embryos were smaller in size than Slc7a5 +/− siblings (Ohgaki et al., 2017) . Because Slc7a5 affects placental function, it is impossible to evaluate organogenesis in mouse embryos unless Slc7a5 knockout with placenta-specific rescue is performed.
Instead of making such mice, we chose to evaluate its function in embryos of Xenopus laevis that develops without a placenta. Xenopus orthologs of SLC7A5 were detected in the eye and notochord starting at the neurula stage. Its functional disruption by a morpholino antisense oligonucleotide (MO) affected early neural and non-neural patterning, primary neurogenesis and eye development. These phenotypes can be caused, at least partially, by notochord malfunction that led to decreased shh/gli signaling.
Material and methods

Embryos
Xenopus laevis eggs were obtained by injecting 300-500 unit of human chorionic gonadotropin, Gonatropin (Aska Pharmaceutical, Tokyo, Japan) to adult female and were fertilized artificially with sperm from adult male. Embryos were dejellied with 1% sodium mercaptoacetate (pH 10) and cultured in 0.1xMMR (Marc's Modified Ringers; 10 mM NaCl, 0.2 mM KCl, 0.1 mM MgCl 2 , 0.2 mM CaCl 2 , 0.5 mM HEPES, pH 7.5). Stages were determined according to normal table of Xenopus laevis (Nieuwkoop and Faber, 1994) .
RT-PCR
Total RNA extraction was performed with ISOGEN (NIPPON GENE, Tokyo, Japan) and reverse transcription was carried out with SuperScript III (Thermo Fisher Scientific, Yokohama, Japan) using Two amino acid sequences, slc7a5.S (NM_001096373) and slc7a5.L (NM_001090065), were aligned by clustalW. Asterisks represent identical amino acid residues. Dots show similar residues. Shaded cysteine is predicted to be participated in a disulfide bond with slc3a2 (4F2hc or CD98) protein. Semi-quantitative RT-PCR was performed to examine the expression of slc7a5 mRNA in the developmental stages. slc7a5.S started to express from the gastrula stage (st.10.5) and increased thereafter. slc7a5.L expression was found maternally and also detected in the zygotic stage. slc3a2 (4F2hc or CD98) expression was detected from st.20. Histone H4 was used as a loading control. −RT represents a negative control without reverse transcriptase. Numbers show developmental stages defined by Nieuwkoop and Faber (1994) . U: unfertilized egg.
0.1 μg of total RNA and oligo dT primer. Sequences of primer sets and cycle numbers were as follows: slc7a5.S forward, 5′-CAA CAA CCA CAA ACT ATT GC-3′; slc7a5.S reverse, 5′-CAA GTT AAG GCA ACA TGT AG-3′ (27 cycles); slc7a5.L forward, 5′-CAC AAA GTT CAT CTC TGT T-3′; slc7a5.L reverse, 5′-CAA ACA GAA AGG TAT AAG AG-3′ (29 cycles); slc3a2 forward, 5′-CCT GCT CAG TCC TCA AGA CC-3′; slc3a2 reverse, 5′-TCA TTC TGG TCC CAG CTT CT-3′ (26 cycles); Histone H4 forward, 5′-CGG GAT AAC ATT CAG GGT ATC ACT-3′; Histone H4 reverse, 5′-ATC CAT GGC GGT AAC TGT CTT CCT-3′ (27 cycles). Negative control (−RT) was performed without reverse transcriptase. All cycle numbers are within the linear range of amplification. T. Katada, H. Sakurai Mechanisms of Development 155 (2019) 48-59 
RT-qPCR
Total RNA extraction from slc7a5 MO-or control MO-injected embryos (both sides) at st.15 was performed with ISOGEN (NIPPON GENE, Tokyo, Japan) and reverse transcription was carried out with SuperScript III (Thermo Fisher Scientific, Yokohama, Japan) using 0.1 μg of total RNA and oligo dT primer. Sequences of primer sets were as follows: chrd.1 forward, 5′-TGG ATG GTC TGC ACA ATG TT-3′; chrd.1 reverse, 5′-GAA TCC AAG GTG GCA AGG TA-3′; shh forward, 5′-GCA CCA GGT CGT TCA AGT CT-3′; shh reverse, 5′-GGC AGT TAG AGG CGC ATA AG-3′; ptch2 forward, 5′-GCC AGC AAG GAT CCA AAT TA-3′; ptch2 reverse, 5′-CTT CTG CTC TTG GCA GGT TC-3′; foxa2 forward, 5′-TCA TGG ACC TGT TCC CTT TC-3′; foxa2 reverse, 5′-GAA TCA GGG TGT AGG GTC CA-3′; gli1 forward, 5′-ACC AAC AGT GGG GAT GAT GT-3′; gli1 reverse, 5′-TCT TGA GAG CTT GGG CTC AT-3′; gli2 forward, 5′-CTC CAT GCT CAC AAC ATT GG-3′; gli2 reverse, 5′-CCC AGG ACC CTA ACG TCT TT-3′; Histone H4 forward, 5′-TAT CAC TAA ACC CGC CAT CC-3′; Histone H4 reverse, 5′-TCT TCC TCT TGG CGT GTT CT-3′. Reaction was performed with SYBR Select Master Mix and 7300 Real Time PCR System (Applied Biosystems) according to the manufacturer's instruction. The data was analyzed using 7300 System Sequence Detection Software Version 1.4.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as described previously (Katada and Sakurai, 2016) . Briefly, the method of Shain and Zuber was employed (Shain and Zuber, 1996) and embryos after signal detection were bleached with a solution containing hydrogen peroxide (Koga et al., 2007; Mayor et al., 1995) . slc7a5.S, slc3a2.L, shh, ptch2, foxa2 (also known as HNF-3β), gli1 and gli2 were obtained by PCR cloning using following primer sets after reverse transcription of total RNAs from Xenopus embryos and these amplified PCR fragments were subcloned into pBIISK+ vector.
slc7a5.S forward, 5′-GGG GGA TCC ATG GCA GCG GGC AGC GTG AA-3′; slc7a5.S reverse, 5′-GGG CTC GAG TTA AGA CTC CTG AGG GAC AG-3′; slc3a2.L forward, 5′-GGG GAA TTC CAA GAC ACC AGG ACT CCG AC-3′; slc3a2.L reverse, 5′-GGG CTC GAG TTA TCC ACT ATA AGG GTA TT-3′; shh forward, 5′-GGG GGA TCC ATG CTG GTT GCG AAC TCG AA-3′; shh reverse, 5′-GGG GAA TTC TCA ACT GGA TTT CGT TGC CA-3′; ptch2 forward, 5′-GGG CTC GAG CCG AAA CCA ACG TTC AGT AC-3′; ptch2 reverse 5′-GGG TCT AGA CTA GTG TTG AAC AGA CAA GT-3′; foxa2 forward, 5′-GGG GAA TTC ATG CTT GGG GCT GTG AAA AT-3′; foxa2 reverse, 5′-GGG CTC GAG CAT GGG ACA GGA CAG AAT GG-3′; gli1 forward, 5′-GGG GAA TTC TGT GAT TAC CAA GGG CAA CA-3′; gli1 reverse, 5′-GGG CTC GAG ACA TTG TGT TTA GGT ACT TA-3′; gli2 forward, 5′-GGG GGA TCC GTC TGT ACA GAG GAA TAT CA-3′; gli2 reverse, 5′-GGG GAA TTC TTA GGA CAT CAG ATT GAG AA-3′. sox2, xk81a1, tubb2b, chrd.1 and pax6 are kind gifts from Dr. Tsutomu Kinoshita (Rikkyo University, Tokyo). The antisense probes for slc7a5.S (BamHI/T7), slc3a2.L (EcoRI/T7) sox2 (EcoRI/T7), xk81a1 (EcoRI/SP6), tubb2b (BamHI/T3), chrd.1 (EcoRI/T7), shh (BamHI/T7), ptch2 (XhoI/ T3), foxa2 (EcoRI/T7), gli1 (EcoRI/T7), gli2 (BamHI/T7) and pax6 (EcoRI/T7) were prepared with restriction enzyme and RNA polymerase shown in the parenthesis in presence of digoxygenin-UTP (Röche Diagnostics).
Histology
Embryos after whole-mount in situ hybridization were dehydrated and embedded in paraffin, Parabett (Muto Pure Chemicals, Tokyo, Japan). Sections were cut at 10 μm. Slides were deparaffinized and mounted with 50% glycerol in PBS. For hematoxylin and eosin staining, sections were cut at 10 μm and slides were processed according to the manufacturer's instruction (Wako Pure Chemical Industries, Osaka, Japan). MO completely matches to slc7a5.S, but has three mismatches to slc7a5.L. Two rescue forms, slc7a5.S rescue and slc7a5.L rescue, have 10 or 11 mismatches to slc7a5 MO with silent mutations. ATG in red represents a start codon and double dots represent the mismatch of the base. (B-J) Validation assay of slc7a5 MO with GFP fusion constructs, slc7a5.S-GFP and slc7a5.L-GFP. GFP construct (0.5 ng) with or without MO (20 ng) was injected into dorsoanimal region of 4-cell stage embryos. GFP fluorescence was observed in the embryos injected with GFP only or GFP and control MO, but slc7a5 MO abolished the fluorescence in both slc7a5.S-GFP and slc7a5.L-GFP co-injection. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Morpholino antisense oligonucleotide (MO) or overexpression of slc7a5 in Xenopus embryos
Morpholino antisense oligonucleotides (MO) were purchased from Gene Tools (OR, USA). Sequences of slc7a5 MO and control MO were as follows; slc7a5 MO, 5′-TCC GCT TCA CGC TGC CCG CTG CCA T-3′; control MO, 5′-CCT CTT ACC TCA GTT ACA ATT TAT A-3′. Total injected amount of MO was 20 ng in all experiments. To verify the inhibitory effect of slc7a5 MO, GFP fusion constructs, slc7a5.S-GFP and slc7a5.L-GFP, were prepared by inserting slc7a5.S and slc7a5.L in frame into pCS2mt-UGP vector, respectively. Sequences of primers for GFP fusion constructs were as follows; slc7a5.S-GFP forward, 5′-GGG GGA TCC AGG CGA AGC CAG TGC CAT GGC AGC GGG CAG CGT G-3′; slc7a5.S-GFP reverse, 5′-GGG TCT AGA AGA CTC CTG AGG GAC AGC CT-3′; slc7a5.L-GFP forward, 5′-GGG ATC GAT CCA TCC AAA GCC AGT GGC ATG GCC GCA GAC AGC GTG-3′; slc7a5.L-GFP reverse, 5′-GGG TCT AGA GGA CTC CTG GGG GAC AGC CT-3′. For rescue experiments, rescue plasmids were constructed by inserting slc7a5.S and slc7a5.L with silent mutations in MO-binding domain into pCS2+ vector, respectively. Sequences of primers for rescue constructs were as follows; slc7a5.S-rescue forward, 5′-GGG GGA TCC ATG GCT GCT GGA TCT GTT AAA AGA AGG CAG TCA GGA-3′; slc7a5.S-rescue reverse, 5′-GGG CTC GAG TTA AGA CTC CTG AGG GAC AG-3′; slc7a5.L-rescue forward, 5′-GGG ATC GAT ATG GCT GCT GAT TCT GTT AAA AGA AGG CAG TCA GGA-3′; slc7a5.L-rescue reverse, 5′-GGG TCT AGA TTA GGA CTC CTG GGG GAC AG-3′. For overexpression experiments, plasmids were constructed by inserting wild-type of slc7a5.S and slc7a5.L into pCS2+ vector, respectively. Sequences of primers for overexpression constructs were as follows; slc7a5.S-oe forward, 5′-GGG GGA TCC ATG GCA GCG GGC AGC GTG AA-3′; slc7a5.S-oe reverse, 5′-GGG CTC GAG TTA AGA CTC CTG AGG GAC AG-3′; slc7a5.L-oe forward, 5′-GGG ATC GAT ATG GCC GCA GAC AGC GTG AA-3′; slc7a5.L-oe reverse, 5′-GGG TCT AGA TTA GGA CTC CTG GGG GAC AG-3′.
All capped RNAs were synthesized with SP6 RNA polymerase. β-Galactosidase RNA was produced from pCMV-SPORT β-gal (Thermo Fisher Scientific, Yokohama, Japan). Microinjection was performed using NANOJECT II Kit (Drummond Scientific Company) and RNAs and/or MOs were unilaterally injected to dorsoanimal region of 4-cell stage embryos and uninjected side was defined as a control side. 
Statistical analysis
All results shown in four tables were analyzed by Chi-square test and p < 0.01 was considered statistically significant.
Results
Spatiotemporal expression of slc7a5 in Xenopus laevis embryos
Two Xenopus orthologs of SLC7A5 gene were found in Xenbase: slc7a5.S (NM_001096373) and slc7a5.L (NM_001090065). We successfully isolated both mRNAs from total RNAs of st.35 embryos. The cysteine residue responsible for the disulfide bridge with slc3a2 was predicted by comparison of slc7a5.S and slc7a5.L with human SLC7A5 (Wagner et al., 2001) (Fig. 1) . By RT-PCR, slc7a5.S started to express at the gastrula stage (st.10.5) while slc7a5.L was already present in the unfertilized egg. Expression levels of these genes gradually increased through neurula stages. To our surprise, expression of slc3a2 mRNA was only observed from st.20 (late neurula) on (Fig. 2) . By whole-mount in situ hybridization, slc7a5.S was expressed throughout animal side of embryos during gastrula stages (Fig. 3A, B) . During neurula stages, slc7a5.S expression was detected in the eye field ( Fig. 3C ) and the notochord extending from the blastopore to the anterior side ( Fig. 3D) . Compared with st.15 embryos, more distinct and stronger expression of the gene was noted in the eye field at st.20 (Fig. 3E) . Expression of slc7a5.S in the notochord at st.20 was confirmed in the transverse section (Fig. 3F ). Interestingly, slc3a2 was detected in the cement grand ( Fig. 3G ) and the neural tube (Fig. 3H ), but not in the eye field or notochord at this stage. Coexpression of slc7a5.S and slc3a2 was observed in the eye at st.25 (Fig. 3I, K, M) . Transverse sections showed both genes were detected in the notochord, however, slc7a5.S was found in the dorsal part of the neural tube while slc3a2 was detected in the ventral part of it (Fig. 3J, L) . Expression of slc7a5.S in the eye, notochord and neural tube was maintained at st.35 (Fig. 3N ). Expression of slc7a5.S was detected in the lens, the cilliary marginal zone (CMZ) of the neural retina, the boundary of the inner nuclear layer (INL) and the outer nuclear layer (ONL), and the retinal pigment epithelium (RPE) in the transverse section of the eye at st.35 (Fig. 3P, Q) . Similar analysis with slc7a5.L probe was performed, and expression pattern of slc7a5.L was identical to that of slc7a5.S at stages between 10.5 and 35 (data not shown).
Inhibition of slc7a5 disrupted early neural development and interfered with eye development
To elucidate the function of slc7a5 in Xenopus early development, we performed loss-of-function experiments using a morpholino antisense oligonucleotide (MO). The purchased slc7a5 MO was completely complementary to slc7a5.S mRNA, and had three mismatches to slc7a5.L mRNA (Fig. 4A ). Two GFP fusion constructs, slc7a5.S-GFP and slc7a5.L-GFP, were prepared to check the ability of slc7a5 MO to inhibit translation ( Fig. 4B-J) . While GFP fluorescence was detected in control MO injection (Fig. 4C, F, I) , the fluorescence from both slc7a5.S-GFP and slc7a5.L-GFP was disappeared by slc7a5 MO (Fig. 4G, J) . Thus, slc7a5 MO bound to not only slc7a5.S but also slc7a5.L mRNA to inhibit translation.
Four-cell stage embryos were unilaterally injected with 20 ng of slc7a5 MO into the dorsoanimal region. Slight left-right asymmetry of the neural fold was seen in slc7a5 MO-injected embryos at st.15 (Fig. 5A, B ). Neural tube closure was completed in control MO-injected embryos at st.20 (Fig. 5C ) while the neural fold in the injected side was separated from the midline in slc7a5 MO-injected embryos (88%, T. Katada, H. Sakurai Mechanisms of Development 155 (2019) 48-59 n = 104; Fig. 5D and Table 1 ). Moreover, slc7a5 depletion led to the eye defect. The mild phenotype (72%, n = 121; Fig. 5J , K and Table 1 ) had a smaller eye compared with that in the control side and the distinct retinal pigment was not observed in the severe phenotype (13%, n = 121; Fig. 5O , P and Table 1 ) at st.35. In the transverse section, the eye structures were disorganized in the slc7a5 MO-injected side to different degrees (Fig. 5L-N and Q-S) . The frequency of these eye defects were significantly reduced by co-injection with rescue constructs of slc7a5.S and slc7a5.L mRNA with slc7a5-MO (mild phenotype 48%, severe phenotype 3%, n = 118; Fig. 5T -X and Table 1 ). Taken together, it is suggested that slc7a5 contributes early neural and eye development in Xenopus.
slc7a5 inhibition disrupted normal retinal morphogenesis
To investigate eye defect caused from slc7a5 depletion in detail, expression of pax6, a marker for the developing retina, and nrl (also known as L-maf), a marker for the lens, were investigated at st.35. Inhibition of slc7a5 led to reduction of pax6 and nrl expression (90%, n = 93 for pax6; 86%, n = 88 for nrl; Fig. 6 and Table 2 ). Thus, slc7a5 is likely to play a critical role in eye development.
slc7a5 depletion disrupted neural-and non-neural patterning and primary neurogenesis
Whole-mount in situ hybridization was performed with gene markers to examine neural development from the mid neurula (st.15) to the late neurula (st.20) in slc7a5-inhibited embryos (Fig. 7) . Two markers, sox2 (a pan neural marker) and xk81a1 (an epidermal keratin marker), were used. Expression of sox2 was decreased in the slc7a5 MO-injected side at st.15 (79%, n = 102; Fig. 7C and Table 3 ). Thereafter, the neural fold did not fuse at the midline in slc7a5-depleted embryos (97%, n = 120; Fig. 7D and Table 3 ). Because the xk81a1-negative region was expanded at st.15 (83%, n = 105; Fig. 7H and Table 3 ), increase in the number of epidermal cells cannot explain the decrease in neural cells. Unlike control MO-injected embryos or the uninjected side, the slc7a5 MO-injected side was not covered by epidermal cells at st.20 (93%, n = 120; Fig. 7I and Table 3 ). These results imply that neural tube does not close properly in slc7a5-depleted embryos.
To investigate whether primary neurons were established, tubb2b (a primary neuron marker, also known as N-tubulin) expression was examined. Motoneurons and interneurons were lost when slc7a5 was inhibited (91% at st.15, n = 99; 90% at st.20, n = 102; Fig. 7M, N and Table 3 ). These effects were reversed by coinjection with slc7a5.S and slc7a5.L rescue constructs mRNA (49%, n = 72 for sox2; 49%, n = 70 for xk81a1; 54%, n = 89 for tubb2b; Fig. 7E , J, O and Table 3 ).
Taken together, it is suggested that slc7a5 contributes to neural-and non-neural patterning and primary neuron formation in Xenopus development.
slc7a5 was essential for shh/gli signaling to induce proper notochordal and neural development
It has been shown that the notochord plays a key role in inducing neural tissues in animal cap assays in Xenopus (reviewed in Sasai and De Robertis, 1997; Kintner, 1992) and that notochordal grafts ectopically induce motoneurons (Yamada et al., 1991; Yamada et al., 1993) . Given strong expression of slc7a5 in the notochord (Fig. 3) , we hypothesized that the reduction of slc7a5 protein in the notochord might compromise notochord function. Therefore, we examined notochord function mainly focused on shh pathway because it plays a central role for this induction (Patten and Placzek, 2002) (Fig. 8) .
Both notochordal markers, chrd.1 and shh, were detected in slc7a5 MO-injected embryos. However, the area of chrd.1 expression spread Table 4 ). Similarly, the area of shh expression spread laterally and shortened anteroposteriorly (80%, n = 75; Fig. 8D , H and Table 4 ). These results indicate that the notochord did not extend enough along anteroposterior axis in slc7a5-depleted embryos. Next, expression of ptch2 and foxa2, both of which mark the notoplate (presumptive floor plate) adjacent to the notochordal tissue, was analyzed. Expression of ptch2, one of receptors of hedgehog, was diminished in the slc7a5 MO-injected side (87%, n = 69; Fig. 8J, N and Table 4 ). The area of foxa2 (also known as HNF-3β) expression, a shh downstream transcription factor, was diffused (84%, n = 75; Fig. 8L , P and Table 4 ). Expression of gli1 and gli2, target genes in shh signaling, was decreased in slc7a5-MO injected side (gli1 reduction in 87%, n = 90; gli2 reduction in 88%, n = 85; Fig. 7R , T and Table 4 ). Expression of these 6 genes, especially genes involved in shh/gli signaling, was reduced by RT-qPCR ( Fig. 8U ). Taken together, slc7a5 is essential for proper notochord development and shh signaling pathway.
3.6. Overexpression of slc7a5.S and slc7a5.L did not affect embryonic development Despite the distinct phenotype by silencing slc7a5, overexpression of either slc7a5.S and/or slc7a5.L RNA did not show any gross abnormality in the embryos (data not shown).
Discussion
In this study, the expression profile of Xenopus slc7a5 in early developmental stages was examined and loss-of-function analysis with slc7a5 MO was performed. Two genes, slc7a5.S and slc7a5.L, existed in Xenopus laevis. Maternal expression of slc7a5.L and zygotic expression of slc7a5.S and slc7a5.L were observed. slc7a5.S was detected in the notochord and eye anlagen at neurula stages and its expression was increased thereafter. Inhibition of slc7a5 disrupted early neural and non-neural patterning and eye development.
Recently, 68% of embryonic lethal phenotypes observed in 103 mouse gene knockout studies turn out to be due to placental defect (Perez-Garcia et al., 2018) . Along the same line, embryonic lethality in Slc7a5 knockout mice can also be explained by placental defect (Ohgaki et al., 2017) . However, the study does not address the physiological functions of Slc7a5 in the placenta. Moreover, placental defect obscures the role of the gene in early stages of development. Because Xenopus embryos develop without a placenta, it was possible to investigate expression pattern and functional roles of this gene during early development. Our focus in this study was in neurula stages, where no other studies have addressed the role of SLC7A5 in humans or other model organism including Xenopus. This is the first study to our knowledge that demonstrates the role of amino acid transporter in the developmental process. As discussed later, it is likely that many of these defects T. Katada, H. Sakurai Mechanisms of Development 155 (2019) 48-59 in slc7a5-depleted embryos are independent of amino acid transport function.
Inhibition of slc7a5 disrupted notochord function
Both allo-alleles of slc7a5 showed similar spatial expression pattern in gastrula-neurula stages; they were localized at the notochord and eye field. The notochord is derived from the Spemann's organizer and secretes chordin and noggin to induce the neural plate tissue. It also secretes shh to establish the dorsoventral polarity in the neural tube (reviewed in Sasai and De Robertis, 1997) . Inhibition of slc7a5 by injecting MO capable of binding to both allo-alleles ( Fig. 4) resulted in shorter notochord anteroposteriorly and less restricted expression of chrd.1 and shh laterally (Fig. 8A-H) . In addition, the expression level of chrd.1 in slc7a5 knockdown embryo was decreased by RT-qPCR ( Fig. 8U ). Thus the presumptive neural plate would be exposed to less chrd.1, a BMP inhibitor, due to lower production and dilution resulting in less inhibition of BMP signaling, which is critical for neural induction. It is likely that this disruption of chrd.1 production led to the decrease of sox2 expression ( Fig. 7A-D) , a marker for neural induction, in slc7a5 MO-injected embryos.
At st.20, tubb2b expression that marks the motoneuron and interneuron was eliminated when slc7a5 was inhibited (Fig. 7M, N) . These two kinds of primary neurons are established in the neural plate with dorsoventral polarity (Sasai and De Robertis, 1997) . It is shown that shh from the notochord induces gli1 and gli2 in the neural plate in normal development (Ruiz i Altaba, 1998) . gli1 and gli2 encode transcriptional factors and overexpression of these genes leads to ectopic formation of primary neurons (Brewster et al., 1998) . Nguyen et al. have shown that downregulation of gli1 or gli2 with MO reduced tubb2b expression and they concluded that gli1 and gli2 are necessary for primary neurogenesis in Xenopus (Nguyen et al., 2005) . In our experiments, expression of shh in the notochord was disrupted (Fig. 8D, H) and that of gli1 and gli2 was reduced when slc7a5 was inhibited with MO ( Fig. 8R, T) . Taken together with previous studies, loss of the motoneuron and interneuron formation in slc7a5 MO-injected embryos can be explained by the disruption of shh signaling pathway in the notochord. It should be noted, however, that primary sensory neuron formation was not affected in our experiments in contrast to Nguyen et al., where gli1 or gli2 inhibition leads to loss of all three primary neurons. We do not have reasonable explanation for this contradictory finding.
Expression of every gene in the notochord or the neural plate examined was down-regulated in slc7a5-depleted embryos (Fig. 8U) . Interestingly, the degree of decrease in expression of shh pathway genes (shh, ptch2, foxa2, gli1 and gli2) was more than that of chrd.1, suggesting that loss of slc7a5 affects more in shh signaling than chordin signaling. On the other hand, these notochord and neural plate genes still main-tained~half of their normal expression levels. Together with the fact that overexpression of slc7a5 did not show any gross defects, it is suggested that effect of slc7a5 on shh is likely to be modulatory rather than its critical determinant.
As shown in Fig. 2, slc3a2 was not detected until late neurula stages. At least in mammals, binding of Slc7a5 to Slc3a2 is shown to be required for plasma membrane expression of Slc7a5 (Mastroberardino et al., 1998; Nakamura et al., 1999) . Therefore, it is possible that slc7a5 in the notochord and the eye did not act as an amino acid transporter before slc3a2 expression. Furthermore, when Xenopus embryos were cultured in the presence of JPH203, a competitive inhibitor of SLC7A5, these embryos did not show the phenotype seen in slc7a5 MO-injected embryos (Katada and Sakurai, unpublished observation), suggesting early developmental defects is independent of amino acid transport function of slc7a5.
slc7a5 and eye development
We found that slc7a5 depletion led to eye defects (Fig. 5) . Many studies have shown that eye development starts with formation of the optic vesicle derived from the forebrain and is accomplished through lots of interaction between cells and molecules (reviewed in Chow and Lang, 2001) . In this process, eye anlagen is specified by EFTFs (eye field transcriptional factors) such as tbx2 (ET), rax (Rx1), pax6, six3, lhx2, nr2e1 (tailless, tll), six6 (optx2) (Zuber et al., 2003) . These genes start to express in the anterior neural plate prior to st.15 (Bachy et al., 2001; Casarosa et al., 1997; Hirsch and Harris, 1997; Hollemann et al., 1998; Li et al., 1997; Mathers et al., 1997; Zhou et al., 2000; Zuber et al., 1999) , when slc7a5 expression in the eye field was barely detected. Therefore, it is likely that slc7a5 is not involved in the establishment of eye primordia, rather slc7a5 contributes to the eye development after neurula stages. Moreover, while slc7a5 expression became more distinct as embryos grew up to st.20, slc3a2 expression was not in the eye field during these stages. Both expression patterns of slc7a5 and slc3a2 were overlapped at st.25, suggesting that slc7a5 before st.20 did not function as an amino acid transporter and it did after st.25 on.
Conclusions
We found that amino acid transporter gene slc7a5 is essential for notochord function of inducing neural development and for eye development in Xenopus. It is likely that disruption of notochord may not be related to amino acid transport. This study sheds a light on yet unexplored field of developmental function of "amino acid transporter gene".
